Cargando…

Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections

BACKGROUND: Multidrug-resistant organism (MDRO) infections are associated with high mortality and readmission rates. Infectious diseases (ID) consultation improves clinical outcomes for drug-resistant Staphylococcus aureus bloodstream infections. Our goal was to determine the association between ID...

Descripción completa

Detalles Bibliográficos
Autores principales: Burnham, Jason P, Olsen, Margaret A, Stwalley, Dustin, Kwon, Jennie H, Babcock, Hilary M, Kollef, Marin H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852998/
https://www.ncbi.nlm.nih.gov/pubmed/29577058
http://dx.doi.org/10.1093/ofid/ofy026
_version_ 1783306684528066560
author Burnham, Jason P
Olsen, Margaret A
Stwalley, Dustin
Kwon, Jennie H
Babcock, Hilary M
Kollef, Marin H
author_facet Burnham, Jason P
Olsen, Margaret A
Stwalley, Dustin
Kwon, Jennie H
Babcock, Hilary M
Kollef, Marin H
author_sort Burnham, Jason P
collection PubMed
description BACKGROUND: Multidrug-resistant organism (MDRO) infections are associated with high mortality and readmission rates. Infectious diseases (ID) consultation improves clinical outcomes for drug-resistant Staphylococcus aureus bloodstream infections. Our goal was to determine the association between ID consultation and mortality following various MDRO infections. METHODS: This study was conducted with a retrospective cohort (January 1, 2006–October 1, 2015) at an academic tertiary referral center. We identified patients with MDROs in a sterile site or bronchoalveolar lavage/bronchial wash culture. Mortality and readmissions within 1 year of index culture were identified, and the association of ID consultation with these outcomes was determined using Cox proportional hazards models with inverse weighting by the propensity score for ID consultation. RESULTS: A total of 4214 patients with MDRO infections were identified. ID consultation was significantly associated with reductions in 30-day and 1-year mortality for resistant S. aureus (hazard ratio [HR], 0.48; 95% confidence interval [CI], 0.36–0.63; and HR, 0.73, 95% CI, 0.61–0.86) and Enterobacteriaceae (HR, 0.41; 95% CI, 0.27–0.64; and HR, 0.74; 95% CI, 0.59–0.94), and 30-day mortality for polymicrobial infections (HR, 0.51; 95% CI, 0.31–0.86) but not Acinetobacter or Pseudomonas. For resistant Enterococcus, ID consultation was marginally associated with decreased 30-day mortality (HR, 0.81; 95% CI, 0.62–1.06). ID consultation was associated with reduced 30-day readmission for resistant Enterobacteriaceae. CONCLUSIONS: ID consultation was associated with significant reductions in 30-day and 1-year mortality for resistant S. aureus and Enterobacteriaceae, and 30-day mortality for polymicrobial infections. There was no association between ID consultation and mortality for patients with resistant Pseudomonas, Acinetobacter, or Enterococcus, possibly due to small sample sizes. Our results suggest that ID consultation may be beneficial for patients with some MDRO infections.
format Online
Article
Text
id pubmed-5852998
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58529982018-03-23 Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections Burnham, Jason P Olsen, Margaret A Stwalley, Dustin Kwon, Jennie H Babcock, Hilary M Kollef, Marin H Open Forum Infect Dis Major Article BACKGROUND: Multidrug-resistant organism (MDRO) infections are associated with high mortality and readmission rates. Infectious diseases (ID) consultation improves clinical outcomes for drug-resistant Staphylococcus aureus bloodstream infections. Our goal was to determine the association between ID consultation and mortality following various MDRO infections. METHODS: This study was conducted with a retrospective cohort (January 1, 2006–October 1, 2015) at an academic tertiary referral center. We identified patients with MDROs in a sterile site or bronchoalveolar lavage/bronchial wash culture. Mortality and readmissions within 1 year of index culture were identified, and the association of ID consultation with these outcomes was determined using Cox proportional hazards models with inverse weighting by the propensity score for ID consultation. RESULTS: A total of 4214 patients with MDRO infections were identified. ID consultation was significantly associated with reductions in 30-day and 1-year mortality for resistant S. aureus (hazard ratio [HR], 0.48; 95% confidence interval [CI], 0.36–0.63; and HR, 0.73, 95% CI, 0.61–0.86) and Enterobacteriaceae (HR, 0.41; 95% CI, 0.27–0.64; and HR, 0.74; 95% CI, 0.59–0.94), and 30-day mortality for polymicrobial infections (HR, 0.51; 95% CI, 0.31–0.86) but not Acinetobacter or Pseudomonas. For resistant Enterococcus, ID consultation was marginally associated with decreased 30-day mortality (HR, 0.81; 95% CI, 0.62–1.06). ID consultation was associated with reduced 30-day readmission for resistant Enterobacteriaceae. CONCLUSIONS: ID consultation was associated with significant reductions in 30-day and 1-year mortality for resistant S. aureus and Enterobacteriaceae, and 30-day mortality for polymicrobial infections. There was no association between ID consultation and mortality for patients with resistant Pseudomonas, Acinetobacter, or Enterococcus, possibly due to small sample sizes. Our results suggest that ID consultation may be beneficial for patients with some MDRO infections. Oxford University Press 2018-03-15 /pmc/articles/PMC5852998/ /pubmed/29577058 http://dx.doi.org/10.1093/ofid/ofy026 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Article
Burnham, Jason P
Olsen, Margaret A
Stwalley, Dustin
Kwon, Jennie H
Babcock, Hilary M
Kollef, Marin H
Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections
title Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections
title_full Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections
title_fullStr Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections
title_full_unstemmed Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections
title_short Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections
title_sort infectious diseases consultation reduces 30-day and 1-year all-cause mortality for multidrug-resistant organism infections
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852998/
https://www.ncbi.nlm.nih.gov/pubmed/29577058
http://dx.doi.org/10.1093/ofid/ofy026
work_keys_str_mv AT burnhamjasonp infectiousdiseasesconsultationreduces30dayand1yearallcausemortalityformultidrugresistantorganisminfections
AT olsenmargareta infectiousdiseasesconsultationreduces30dayand1yearallcausemortalityformultidrugresistantorganisminfections
AT stwalleydustin infectiousdiseasesconsultationreduces30dayand1yearallcausemortalityformultidrugresistantorganisminfections
AT kwonjennieh infectiousdiseasesconsultationreduces30dayand1yearallcausemortalityformultidrugresistantorganisminfections
AT babcockhilarym infectiousdiseasesconsultationreduces30dayand1yearallcausemortalityformultidrugresistantorganisminfections
AT kollefmarinh infectiousdiseasesconsultationreduces30dayand1yearallcausemortalityformultidrugresistantorganisminfections